Stock Performance and Market Context
On 19 Dec 2025, National Peroxide's stock price touched an intraday low of Rs.471, representing a fall of 3.22% during the trading session. This new low also stands as the company’s all-time lowest price, underscoring the sustained downward pressure on the stock. The day’s performance showed a decline of 1.90%, underperforming its sector by 1.44%. This movement followed two consecutive days of gains, signalling a reversal in short-term momentum.
In contrast, the broader market displayed strength, with the Sensex opening 274.98 points higher and trading at 84,929.36, a 0.53% gain. The benchmark index remains just 1.45% shy of its 52-week high of 86,159.02, supported by bullish moving averages where the 50-day moving average is positioned above the 200-day moving average. Mid-cap stocks led the market rally, with the BSE Mid Cap index gaining 1.26% on the day.
Technical Indicators Highlight Weakness
National Peroxide’s share price is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning reflects a sustained bearish trend and suggests limited short-term support levels. The stock’s failure to hold above these averages contrasts with the broader market’s positive technical setup, highlighting company-specific pressures.
Just made the cut! This Mid Cap from the Heavy Electrical Equipment sector entered our elite Top 1% list recently. Discover it before the crowd catches on!
- - Top-rated across platform
- - Strong price momentum
- - Near-term growth potential
Long-Term Performance and Financial Metrics
Over the past year, National Peroxide’s stock has recorded a return of approximately -44.10%, a stark contrast to the Sensex’s positive 7.21% return over the same period. The stock’s 52-week high was Rs.898.85, indicating a substantial decline from its peak. This performance is further reflected in the company’s long-term financial indicators.
Operating profits have shown a compound annual growth rate (CAGR) of -135.58% over the last five years, signalling a contraction in core earnings. The company’s ability to service its debt is limited, with an average EBIT to interest ratio of 0.14, indicating that earnings before interest and tax cover interest expenses by a narrow margin. Return on equity (ROE) averages at 1.90%, suggesting modest profitability relative to shareholders’ funds.
Recent Earnings and Profitability Trends
In the latest six-month period ending September 2025, the company reported a profit after tax (PAT) of Rs.1.28 crore, which reflects a decline of 77.78% compared to the previous corresponding period. Non-operating income for the quarter accounted for 263.49% of profit before tax (PBT), indicating that a significant portion of earnings is derived from sources outside the company’s core operations.
Profitability challenges are further underscored by negative operating profits and a fall in profits by 113% over the past year. These factors contribute to the stock’s classification as risky relative to its historical valuation levels.
Comparative Market Performance
National Peroxide has underperformed the BSE500 index across multiple time frames, including the last three years, one year, and three months. This underperformance highlights the company’s struggles relative to a broad market benchmark. The stock’s returns over the past year, at -44.98%, contrast sharply with the positive trends seen in the wider market indices.
Considering National Peroxide ? Wait! SwitchER has found potentially better options in Commodity Chemicals and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - Commodity Chemicals + beyond scope
- - Top-rated alternatives ready
Shareholding and Sectoral Position
National Peroxide operates within the commodity chemicals sector, a segment characterised by cyclical demand and pricing pressures. The company’s majority shareholding is held by promoters, indicating concentrated ownership. Despite the sector’s overall dynamics, National Peroxide’s stock has not mirrored the broader market’s positive momentum.
The company’s market capitalisation grade is relatively low, reflecting its micro-cap status and the challenges it faces in scaling operations and profitability. This status is consistent with the stock’s recent price behaviour and financial results.
Summary of Key Price and Performance Metrics
To summarise, National Peroxide’s stock has reached a new low of Rs.471, down from a 52-week high of Rs.898.85. The stock’s performance over the last year shows a decline of over 44%, contrasting with the Sensex’s positive returns. Financial indicators reveal contraction in operating profits, limited debt servicing capacity, and low return on equity. The stock trades below all major moving averages, signalling continued downward pressure.
Meanwhile, the broader market environment remains constructive, with the Sensex near its 52-week high and mid-cap stocks leading gains. This divergence highlights company-specific factors influencing National Peroxide’s share price trajectory.
Only Rs. 14,999 - Get MojoOne + Stock of the Week for 1 Year PLUS 18 Months FREE! Claim Your Free Year →
